Brain-Derived Extracellular Vesicles Induce Vasoconstriction and Reduce Cerebral Blood Flow in Mice.
Brain-Derived Extracellular Vesicles Induce Vasoconstriction and Reduce Cerebral Blood Flow in Mice.
复制标题
DOI:
10.1089/neu.2021.0274
复制
发表时间:
2022-03
影响因子:
4.2
通讯作者:
Ji-wei Wang;Xiaofeng Xie;Yingang Wu;Yuan Zhou;Qi-feng Li;Ying Li;Xin Xu;Min Wang;Lydia S. Murdiyarso;Katie L. Houck;Tristan Hilton;Dominic Chung;Min Li;Jian-Ning Zhang;Jingfei Dong
中科院分区:
文献类型:
--
作者:
Ji-wei Wang;Xiaofeng Xie;Yingang Wu;Yuan Zhou;Qi-feng Li;Ying Li;Xin Xu;Min Wang;Lydia S. Murdiyarso;Katie L. Houck;Tristan Hilton;Dominic Chung;Min Li;Jian-Ning Zhang;Jingfei Dong
Traumatic brain injury (TBI) impairs cerebrovascular autoregulation and reduces cerebral blood flow (CBF), leading to ischemic secondary injuries. We have shown that injured brains release brain-derived extracellular vesicles (BDEVs) into circulation, where they cause a systemic hypercoagulable state that rapidly turns into consumptive coagulopathy. BDEVs induce endothelial injury and permeability, leading to the hypothesis that they contribute to TBI-induced cerebrovascular dysregulation. In a study designed to test this hypothesis, we detected circulating BDEVs in C57BL/6J mice subjected to severe TBI, reaching peak levels of 3x104/µl at 3 hours post injury (71.2±21.5% of total annexin V-binding EVs). We further showed in an adaptive transfer model that 41.7±5.8% of non-injured mice died within 6 hours after being infused with 3x104/µl of BDEVs. BDEVs transmigrated through the vessel walls, induced rapid vasoconstriction by inducing calcium influx in vascular smooth muscle cells, and reduced CBF by 93.8±5.6% within 30 minutes after infusion. The CBF suppression was persistent in mice that eventually died but it recovered quickly in surviving mice. It was prevented by the calcium channel blocker nimodipine. When being separated, neither protein nor phospholipid components from the lethal number of BDEVs induced vasoconstriction, reduced CBF, and caused death. These results demonstrate a novel vasoconstrictive activity of BDEVs that depends on the structure of BDEVs and contributes to TBI-induced disseminated cerebral ischemia and sudden death.